BlackRock, Inc. 13D and 13G filings for Amicus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-23 8:14 pm Sale |
2025-03-31 | 13G | Amicus Therapeutics, Inc. FOLD |
BlackRock Inc. BLK |
22,765,804 7.400% |
-5,138,532 (-18.41%) |
Filing |
| 2025-02-05 1:23 pm Purchase |
2024-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
BlackRock Inc. BLK |
27,904,336 9.300% |
4,918,894 (+21.40%) |
Filing |
| 2024-01-26 11:49 am Purchase |
2023-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
BlackRock Inc. BLK |
22,985,442 7.800% |
2,851,450 (+14.16%) |
Filing |
| 2023-01-31 1:58 pm Purchase |
2022-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
BlackRock Inc. BLK |
20,133,992 7.200% |
323,644 (+1.63%) |
Filing |
| 2022-02-02 7:11 pm Sale |
2021-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
BlackRock Inc. BLK |
19,810,348 7.100% |
-2,067,094 (-9.45%) |
Filing |
| 2021-01-28 5:55 pm Purchase |
2020-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
BlackRock Inc. BLK |
21,877,442 8.400% |
1,021,335 (+4.90%) |
Filing |